These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 32588185)

  • 21. Acute Motor Axonal Neuropathy Related to COVID-19 Infection: A New Diagnostic Overview.
    Petrelli C; Scendoni R; Paglioriti M; Logullo FO
    J Clin Neuromuscul Dis; 2020 Dec; 22(2):120-121. PubMed ID: 33214404
    [No Abstract]   [Full Text] [Related]  

  • 22. Guillain-Barré-Strohl syndrome and COVID-19: Case report and literature review.
    Diez-Porras L; Vergés E; Gil F; Vidal MJ; Massons J; Arboix A
    Neuromuscul Disord; 2020 Oct; 30(10):859-861. PubMed ID: 32912716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guillain-Barré syndrome associated with leptomeningeal enhancement following SARS-CoV-2 infection.
    Sancho-Saldaña A; Lambea-Gil Á; Liesa JLC; Caballo MRB; Garay MH; Celada DR; Serrano-Ponz M
    Clin Med (Lond); 2020 Jul; 20(4):e93-e94. PubMed ID: 32518103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Case of Guillain-Barré Syndrome Associated With COVID-19.
    Rajdev K; Victor N; Buckholtz ES; Hariharan P; Saeed MA; Hershberger DM; Bista S
    J Investig Med High Impact Case Rep; 2020; 8():2324709620961198. PubMed ID: 32981333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-infectious Guillain-Barré syndrome related to SARS-CoV-2 infection: a case report.
    Riva N; Russo T; Falzone YM; Strollo M; Amadio S; Del Carro U; Locatelli M; Filippi M; Fazio R
    J Neurol; 2020 Sep; 267(9):2492-2494. PubMed ID: 32458192
    [No Abstract]   [Full Text] [Related]  

  • 26. Frequency of five unusual presentations in patients with COVID-19: results of the UMC-19-S
    Miró Ò; Llorens P; Jiménez S; Piñera P; Burillo-Putze G; Martín A; Martín-Sánchez FJ; González Del Castillo J;
    Epidemiol Infect; 2020 Aug; 148():e189. PubMed ID: 32843127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guillain-Barré syndrome following COVID-19: new infection, old complication?
    Padroni M; Mastrangelo V; Asioli GM; Pavolucci L; Abu-Rumeileh S; Piscaglia MG; Querzani P; Callegarini C; Foschi M
    J Neurol; 2020 Jul; 267(7):1877-1879. PubMed ID: 32333166
    [No Abstract]   [Full Text] [Related]  

  • 28. Facial diplegia, a possible atypical variant of Guillain-Barré Syndrome as a rare neurological complication of SARS-CoV-2.
    Juliao Caamaño DS; Alonso Beato R
    J Clin Neurosci; 2020 Jul; 77():230-232. PubMed ID: 32410788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severe rapidly progressive Guillain-Barré syndrome in the setting of acute COVID-19 disease.
    Abrams RMC; Kim BD; Markantone DM; Reilly K; Paniz-Mondolfi AE; Gitman MR; Choo SY; Tse W; Robinson-Papp J
    J Neurovirol; 2020 Oct; 26(5):797-799. PubMed ID: 32720233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurological Disorders Identified during Treatment of a SARS-CoV-2 Infection.
    Wada S; Nagasaki Y; Arimizu Y; Shimo M; Matsukuma Y; Okamoto M; Yoshida S; Ohashi I; Hashimoto G; Kuwashiro T; Yasaka M; Okada Y
    Intern Med; 2020 Sep; 59(17):2187-2189. PubMed ID: 32713924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19 and Guillain-Barré syndrome.
    Joob B; Wiwanitkit V
    Rev Neurol (Paris); 2020 Sep; 176(7):637. PubMed ID: 32410748
    [No Abstract]   [Full Text] [Related]  

  • 32. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence?
    Zhao H; Shen D; Zhou H; Liu J; Chen S
    Lancet Neurol; 2020 May; 19(5):383-384. PubMed ID: 32246917
    [No Abstract]   [Full Text] [Related]  

  • 33. Guillain-Barré Syndrome in a Patient With Minimal Symptoms of COVID-19 Infection.
    Oguz-Akarsu E; Ozpar R; Mirzayev H; Acet-Ozturk NA; Hakyemez B; Ediger D; Karli N;
    Muscle Nerve; 2020 Sep; 62(3):E54-E57. PubMed ID: 32497292
    [No Abstract]   [Full Text] [Related]  

  • 34. COVID-19: A Review for the Pediatric Neurologist.
    Christy A
    J Child Neurol; 2020 Nov; 35(13):934-939. PubMed ID: 32660309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New clinical manifestation of COVID-19 related Guillain-Barrè syndrome highly responsive to intravenous immunoglobulins: two Italian cases.
    Assini A; Benedetti L; Di Maio S; Schirinzi E; Del Sette M
    Neurol Sci; 2020 Jul; 41(7):1657-1658. PubMed ID: 32468450
    [No Abstract]   [Full Text] [Related]  

  • 36. HLA and immunological features of SARS-CoV-2-induced Guillain-Barré syndrome.
    Gigli GL; Vogrig A; Nilo A; Fabris M; Biasotto A; Curcio F; Miotti V; Tascini C; Valente M
    Neurol Sci; 2020 Dec; 41(12):3391-3394. PubMed ID: 33006723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Letter to the editor. Concerning the article entitled ''Guillain Barre syndrome associated with COVID-19 infection: A case report".
    Karimi N; Sedaghat Z
    J Clin Neurosci; 2020 Sep; 79():257-258. PubMed ID: 33070907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Guillain-Barré syndrome associated with SARS-CoV-2 infection. Comments after 16 published cases.
    Guijarro-Castro C; Rosón-González M; Abreu A; García-Arratibel A; Ochoa-Mulas M
    Neurologia (Engl Ed); 2020; 35(6):412-415. PubMed ID: 32565036
    [No Abstract]   [Full Text] [Related]  

  • 39. Two cases of skin manifestations prior to the onset of COVID-19 respiratory symptoms.
    Altayeb A; Cordaro A; Caesar J; Vyas J; Ingram J
    Int J Dermatol; 2020 Dec; 59(12):1541-1542. PubMed ID: 33084036
    [No Abstract]   [Full Text] [Related]  

  • 40. Guillain-Barre syndrome during COVID-19 pandemic: an overview of the reports.
    Rahimi K
    Neurol Sci; 2020 Nov; 41(11):3149-3156. PubMed ID: 32876777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.